Schedule 13G ownership disclosure
INSYS THERAPEUTICS INC
Security class unavailable · CUSIP: 45824V209
Event date: 2019-02-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,740,852
- Percent of class
- 5.0400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-19-002688
- Form type
- SC 13G
- Filer
- ETF MANAGERS GROUP, LLC
- CIK
- CIK 1645173
- Filed
- Feb 19, 2019
- Reporting period
- Feb 15, 2019
- Description
- Schedule 13G beneficial ownership